Stem cell mechanism of action in neuroplasticity after stroke
Egyptian Pharmaceutical Journal, ISSN: 2090-9853, Vol: 22, Issue: 3, Page: 344-352
2023
- 1Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures1
- Readers1
Review Description
Stroke is the second leading cause of death in the world that may cause a permanent disability. In recent years, stem cell therapy for ischemic stroke has made great progress. Currently, there have been several studies on stem cell therapy in stroke that provide benefits for neuroplasticity using various cell sources and transplant procedures, but the mechanisms are still controversial. Therefore, the aim of this review was to analyze the various mechanisms of stem cells in enhancing neuroplasticity. Stem cell mechanism that increases neuroplasticity can be through various signaling pathways, namely the endothelin-3/EDNRB, SRY-related HMG-box 10 (SOX10), Wnt/β-Catenin, GF1R+ and C-X-C chemokine receptor type 4 (CXCR4) pathways, and through neurotrophic factor (NT-3), specialized extracellular matrix perineuronal net (ECM PNN), microRNA (miR-133b and Ex-miR-17-92+ cluster), as well as modulation of proteins namely phosphorylated collapsin response mediator protein 2 (CRMP2) and increased regulation of phosphorylated-cAMP response element-binding protein (p-CREB), growth associated protein 43 (GAP-43), and synaptophysin (SYP). In conclusion, various signaling pathways and other factors contribute in neuroplasticity increase due to stem cell therapy in stroke.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know